By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Simvastatin

Simvastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|600 words

Simvastatin Drug Profile

What is Simvastatin?

Simvastatin is a cholesterol-lowering medication belonging to a class of drugs called statins (HMG-CoA reductase inhibitors). It is primarily prescribed to reduce elevated cholesterol levels and lower the risk of cardiovascular events such as heart attacks and strokes. Simvastatin is one of the most widely prescribed statins and has been extensively studied for its cardiovascular benefits.

Uses

Simvastatin is approved for several cardiovascular conditions:

  • High cholesterol (hypercholesterolemia): Reduces LDL (“bad”) cholesterol and total cholesterol levels when diet and exercise alone are insufficient
  • Prevention of cardiovascular events: Lowers risk of heart attack, stroke, and cardiovascular death in patients with existing heart disease or diabetes
  • Primary prevention: Reduces cardiovascular risk in patients with multiple risk factors but no existing heart disease
  • Familial hypercholesterolemia: Treats inherited conditions causing extremely high cholesterol levels
  • Mixed dyslipidemia: Helps normalize various blood lipid abnormalities including elevated triglycerides

How it works

Simvastatin works by blocking HMG-CoA reductase, an enzyme that plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, the drug reduces the liver’s ability to manufacture cholesterol, forcing the body to remove cholesterol from the bloodstream to meet its needs. This mechanism effectively lowers blood cholesterol levels and may also have additional anti-inflammatory effects that benefit cardiovascular health.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or pain (myalgia)
  • Abdominal pain
  • Nausea
  • Constipation
  • Upper respiratory tract infections
  • Dizziness
  • Skin rash

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, weakness, or tenderness (potential rhabdomyolysis)
  • Dark-colored urine or decreased urination
  • Yellowing of skin or eyes (jaundice)
  • Unexplained fatigue or weakness
  • Severe allergic reactions

Warnings and precautions

  • Liver function: Regular monitoring of liver enzymes is recommended, especially during the first year of treatment, as simvastatin can rarely cause liver damage
  • Muscle toxicity: Risk increases with higher doses (especially 80mg) and certain drug combinations; patients should report unexplained muscle pain immediately
  • Pregnancy and breastfeeding: Contraindicated during pregnancy (Category X) and breastfeeding due to potential harm to developing fetuses and infants
  • Kidney disease: Use with caution in patients with kidney impairment, as drug clearance may be reduced
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and may require lower doses

Interactions

Simvastatin has several important drug interactions that can increase the risk of side effects:

  • Warfarin: May enhance anticoagulant effects, requiring more frequent INR monitoring
  • Gemfibrozil and other fibrates: Significantly increases risk of muscle toxicity and rhabdomyolysis
  • Cyclosporine: Dramatically increases simvastatin levels, contraindicated combination
  • Amiodarone: Increases muscle toxicity risk, simvastatin dose should be limited
  • Grapefruit juice: Can increase drug levels and toxicity risk when consumed in large quantities
  • Erythromycin and clarithromycin: These antibiotics can increase simvastatin concentrations
  • Niacin (high doses): May increase risk of muscle problems when combined with simvastatin
  • Protease inhibitors: HIV medications can significantly increase simvastatin levels

Check interactions with the GMJ Interaction Checker

Dosage

Simvastatin is typically taken once daily in the evening, as cholesterol synthesis peaks during nighttime hours. Standard adult dosing ranges from 5mg to 40mg once daily, with most patients starting at 10-20mg daily. The maximum recommended dose is 40mg daily for most patients, though 80mg may be used in certain cases under close medical supervision. Dosage should be individualized based on patient response, cardiovascular risk factors, and tolerability. All dosing decisions should be made by a healthcare provider who will consider the patient’s specific medical history, other medications, and treatment goals.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Simvastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/simvastatin-3/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Fluvastatin

By
GMJ News Desk
01/06/2026

Atorvastatin

By
GMJ News Desk
01/06/2026

Lovastatin

By
GMJ News Desk
01/06/2026

Simvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up